glutaral has been researched along with Blood Loss, Postoperative in 1 studies
Glutaral: One of the protein CROSS-LINKING REAGENTS that is used as a disinfectant for sterilization of heat-sensitive equipment and as a laboratory reagent, especially as a fixative.
glutaraldehyde : A dialdehyde comprised of pentane with aldehyde functions at C-1 and C-5.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stone, WM | 1 |
| Cull, DL | 1 |
| Money, SR | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Prospective, Multi-center, Randomized Study to Evaluate the Safety and Efficacy of ArterX Vascular Sealant.[NCT00759681] | Phase 3 | 217 participants (Actual) | Interventional | 2008-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
The Primary Safety Endpoint Will be the Cumulative Incidence of Significant Bleeding, Infection, Neurological Deficit or Inflammatory/Immune Allergic Response Through 6 Weeks. (NCT00759681)
Timeframe: Treatment through 6 weeks
| Intervention | participants (Number) |
|---|---|
| Control Treatment | 64 |
| Investigational Device | 51 |
The immediate sealing evidenced by no bleeding on clamp release was measured at time of surgery (NCT00759681)
Timeframe: Immediate at time of surgery
| Intervention | Treatment sites (Number) |
|---|---|
| Control Treatment | 65 |
| Investigational Device | 101 |
1 trial available for glutaral and Blood Loss, Postoperative
| Article | Year |
|---|---|
A randomized prospective multicenter trial of a novel vascular sealant.
Topics: Aged; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Female; Gelatin Sponge, Absorba | 2012 |